Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multicenter Randomized Study on the Efficacy of Intravenous Iron Injection in Cancer Patients with Anemia
KCT0004311Phase 3Completed
- Sponsor
- JW Pharmaceutical Corporation
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of Iron in anaemia, sponsored by JW Pharmaceutical Corporation. Started Dec 2019; status: completed.
02
Drugs
Iron
03
Conditions
anaemia
Beyond the preview
Go deeper on KCT0004311.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0004311.